Skip to main navigation
Skip to search
Skip to main content
University of Copenhagen Research Portal Home
Help & FAQ
Dansk
English
Home
Profiles
Research output
Research units
Press/Media
Activities
Prizes
???studenttheses???
Datasets
Search by expertise, name or affiliation
What lurks in the shadows of the openness hyperbole for biopharmaceuticals?
Neethu Rajam,
Timo Minssen
1
Citation (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'What lurks in the shadows of the openness hyperbole for biopharmaceuticals?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Biological Products
98%
Biosimilar Pharmaceuticals
69%
Confidentiality
60%
Drug Development
47%
Clinical Trials
32%
Chemical Compounds
Transparency
100%
Drug
26%